Clinical Trial Update: Namodenoson Treatment of Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for Namodenoson in advanced pancreatic cancer (pancreatic adenocarcinoma). The Phase 2 study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Namodenoson (Namodenoson)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer | Phase 2 | Status: RECRUITING